Skip to main content Skip to navigation

News

Select tags to filter on
10 Sep

NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman

NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, today announced that it has closed a c. £10 million (c. $13 million) financing round.

25 Jul

4D Medicine raises £3.4m for unique biomaterial platform

4D Medicine, a spin-out from the Universities of Birmingham and Warwick has raised £3.4m ($4.4m) in a Series A investment.

17 Jul

Double win for Cytecom at Medilink Awards

Warwick spinout Cytecom wins twice at Medilink Healthcare Business Awards

09 Jul

Patchs Health wins again

For the second year running, Patchs Health has been recognised at the Health Tech Digital Awards.

Tags: spinouts, award
01 May

Warwick Acoustics completes £7m funding round

The spinout company whose patented loudspeaker technology is set to revolutionise in-car audio systems has raised a further £7m in a funding round led by Mercia and including NFU Mutual and private investors.

11 Apr

Clinical trials success for Medherant

Warwick spinout Medherant is pleased to announce preliminary results of trials of its testosterone patch for post menopausal women.

Older news